Global Microbiome contract manufacturing Market Size, Share, Revenue Analysis By Key Players, Market Size, Share, Key Developments, And Forecast 2030

Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

The USD 300 million (by 2030) financial opportunity within the microbiome contract manufacturing market has been analysed across the following segments:

Type of Product Manufactured

·        Active Pharmaceutical Ingredients (APIs)

·        Finish Drug Formulations (FDFs)

Type of Type of Formulation

·        Solid Formulations

·        Oral Liquids

·        Injectables

·        Others

Scale of Operation

·        Clinical

·        Commercial

Company Size

·        Small-sized

·        Mid-sized

·        Large

Key Geographical Regions

·        North America

·        Europe

·        Asia-Pacific and Rest of the World

The Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

·        Bristol Myers Squibb

·        GlaxoSmithKline

·        Incyte

·        Novartis

·        Trillium Therapeutics

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Company Profiles

6. Regional Capability Analysis

7. Likely Partner Analysis

8. Clinical Trial Analysis

9. Capacity Analysis

10. Demand Analysis

11. Make versus Buy Decision Making Framework

12. Microbiome related initiatives of Big Pharmaceutical Players

13. Market Forecast

14. Conclusion

15. Executive Insights

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

18. Appendix 3: List of Probiotic Supplement Contract Manufacturers and

Microbial Contract Service Providers

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com